Abstract-Hypertensive crises require immediate therapy, usually by parenteral drug administration.
However, the blood pressure fall following nifedipine is frequently associated with side effects.
The use of sublingual captopril has recently been indicated in hyper tensive crisis, assuming that by this route, there would be a faster absorption and thus a more rapid effect on blood pressure than with the oral route. To verify this hypothesis, we have compared the hypotensive effects of sublingual nifedipine and sublingual captopril in 52 patients with hypertensive emergencies:
25-mg captopril and 1 0-mg nifedipine were administered sublingually to 28 and 24 patients, respec tively. Blood pressures and heart rates were continuously measured up to 240 min postdose.
A significant (P<0.001) hypotensive effect of both sublingual captopril and nifedipine therapy occured at 5 min and persisted for 240 min. Heart rates increased with nifedipine, but decreased with captopril. We observed no side effects in the captopril group, but flushing, tachycardia and headache were observed in 6 patients in the nifedipine group.
We conclude that sublingual captopril is effective in patients with hypertensive emergencies and that captopril may be an excellent alternative to sublingual nifedipine in the urgent treatment of hypertensive crisis.
It is well-known that sublingual nifedipine is highly effective in the treatment of hyper tensive crisis (1) (2) (3) . However, the decrease of blood pressure following nifedipine is fre quently associated with a reflex tachycardia and flushing. These side-effects, particularly tachycardia, may be hazardous in hypertensive crisis associated with angina pectoris.
Several oral antihypertensive agents have recently been studied in hypertensive crisis. Oral captopril therapy has been found to be effective in hypertensive situations, but usually needs 1-2 hours to achieve a maxi mum effect (4) (5) (6) .
In this study, we administered sublingual captopril to seek a potential alternative drug to sublingual nifedipine in patients with hy pertensive emergencies.
Materials and Methods
Fifty-two patients (12 males and 40 females) who participated in this study were subdivided into the two groups: 24 patients (18 females and 6 males, aged 58±3 years (mean±S.E.M.), and weighing 66±3 kg) in the nifedipine group and 28 patients (22 femeles and 6 males, aged 54±2 years, and weighing 54±2 kg) in the captopril group. All patients had blood pressure higher than 180/ 120 mmHg in two different measurements, five minutes apart. All of the patients were admitted to the emergency department with symptoms of acute hypertensive crises, and they agreed to take part in the present study. Each patient was told to chew the capsule of nifedipine (10 mg 
Results
There was no significant difference be tween the demographic data of the two treat ment groups. The mean(±S.E.M.) pre and postdose blood pressures and heart rates in the two treatment groups are summarized in Table 1 . The mean blood pressure and heart rate data before and up to 240 min after both sublingual dosings are shown in Figs. 1 and 2 , respec tively. A significant (P<0.001) blood pressure reduction occurred at 5 min postdose and persisted throughout the entire observation period after the sublingual administration of both nifedipine and captopril (Table 1) , as compared with the respective predose or baseline blood pressure values. Nifedipine in creased heart rates significantly (P<0.05 to P<0.01) at 5 to 240 min postdose, whereas captopril decreased heart rates significantly (P<0.001) at 15 to 240 min postdose (Table  1) .
When the hypotensive effects of these two drugs were compared, sublingual nifedipine had a more (P<0.05 to P<0.001) hy potensive effect than sublingual captopril at 10 to 240 min postdose (Fig. 1) . The mean values for heart rate compared between nifedipine and captopril at 5 to 240 min did not reach statistically significant differences (Fig. 2) , although nifedipine increased the postdose heart rate from the baseline.
No one complained of any side-effects in the captopril group, but 6 patients (25%) in the nifedipine group complained of flushing, hydralazine and methyldopa has been a generally accepted strategy for the treatment of hypertensive emergency (7). Nifedipine has been found to be efficient in the treatment of hypertensive emergency with advantage of being a non-parenteral agent (1-3). Houston et al. (1), who reviewed 21 studies (totally 455 patients), concluded that nifedipine administered orally, sublingually, buccaly or rectally in hypertensive urgencies produces a prompt, consistent, dose-related and safe reduction in arterial pressure with few side-effects.
Serious and sometimes fatal complications of treatment in hypertensive crises have been reported for nearly all drugs, such as sodium nitroprusside, diaxozide, methyldopa and hydralazine (8) . Sublingual nifedipine has been a preferred agent for hypertensive crisis with increasing cerebral blood flow (2) .
Captopril is effective in many forms of hypertension and especially indicated for patients with a high-renin hypertension or hypertension complicated by diabetes mel litus or congestive heart failure (6, 9, 10) as well as with hypertensive emergency . For example, Tschollar and Belz (1 1) reported the effects of sublingual captopril in hyper tensive crises. The other studies confirmed the efficacy of sublingual captopril and noted that the hypotensive effect persisted for several hours with a duration similar to an oral dose (12, 13) .
Hauger-Klevene (14) compared the hypo tensive effect of sublingual captopril with that of sublingual nifedipine.
The results showed the similar hypotensive effect, but the decrease in blood pressure levels induced by sublingual nifedipine occurred earlier than by sublingual captopril. Opie Brunner et al. (18) found that intravenous enalapril and nifedi pine were equally effective in acutely lowering blood pressure.
In our study both of the drugs sublingually administered aecreased blood pressures similarly (P<0.001) and these effects per sisted during 240 min. However, the hypo tensive effect of sublingual nifedipine was somewhat more powerful than that of sublin gual captopril, but we observed some side effects only in the nifedipine group.
We concluded that both nifedipine and captopril sublingually administered are effec tive and safe alternative drugs for managing hypertensive emergencies. They will be used as a first-line drug in the treatment of this con dition, since they are easy to administer, they have a rapid onset of action, and they do not induce an exaggerated fall in blood pressure. Captopril with no apparent side-effect(s) seems to be a potential alternative drug for the treatment of hypertensive emergencies. Thus, sublingual captopril appears to be more promising, while further studies are obviously necessary to compare it to other antihyper tensive regimens used for the treatment of hypertensive emergency.
